“…In a previous paper, a semisynthetic derivative of quercetin, 2-(2,2-diphenylbenzo[d] [1,3] dioxol-5-yl)-5,7-dihydroxy-4-oxo-4H-chromen-3-yl oleate, was synthesized according to Steglich conditions and validated as a potential insulin secretagogue agent G-protein-coupled receptor 40 ligand [3]. In this context, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4H-chromen-3-yl oleate, quercetin-3-oleate, was synthesized avoiding the preventive catechol protection but considering several literature observations [7], considering that Candida antartica Lipase B ® -the most used acylating enzyme-was not able to produce esters of quercetin [8]. In a typical optimized experiment, one equivalent of quercetin, and one equivalent of oleic acid were added to PPL and acetone.…”